Overview
At Elysium Biotech Solutions, we are harnessing advanced computational biology to revolutionize drug discovery. Our proprietary platform combines machine learning algorithms and genomic data analysis to identify potential drug candidates faster and more efficiently than traditional methods. Since our inception in early 2024, we have developed a robust prototype and successfully conducted initial trials that have demonstrated a higher than average success rate in identifying viable compounds. Our early traction includes partnerships with two leading pharmaceutical companies who are enthusiastic about integrating our platform into their R&D processes. This not only validates our technology but also creates a clear pathway to revenue generation. With a growing market that is projected to expand to $200 billion by 2030, we are poised to capture significant market share with our innovative solutions. To take our operations to the next level, we are seeking investment to boost our research capabilities, expand our team, and enhance our technology infrastructure. With the funds, we aim to hire additional data scientists and biologists, scale our marketing efforts to reach a broader client…
Use of funds
The requested $2,500,000 will be allocated as follows:
- Research and Development (40%): Enhancing our platform's capabilities and expanding our technology.
- Hiring (30%): Recruiting top-tier talent in data science and biology to strengthen our team.
- Marketing and Sales (20%): Targeted outreach to pharmaceutical companies and increasing brand awareness.
- Operational Expenses (10%): Covering necessary overheads to sustain growth.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.